Zimbabwe has rejected a major US healthcare agreement worth 367 million US dollars (£272m) over five years because of the United States' demand for confidential information.
This move came to light following a government memo from December was disclosed, indicating that Head of State Emmerson Mnangagwa felt the arrangement was "unbalanced".
A government spokesperson later clarified that the United States was demanding access to health data for research and profit while was unwilling to share the resulting advantages from any future treatments.
"We are forced to start the difficult and regrettable process of winding down our health aid in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy said the US had furnished more than $1.9bn as health assistance to Zimbabwe over the last two decades.
A medical body in Zimbabwe has called for continued talks to reach a agreement acceptable to both sides so the country's critical HIV programme can proceed.
Wider Implications
This development comes after a similar situation in neighbouring Kenya, where a high court suspended a related health funding agreement following legal challenges were filed about the security of Kenyans' medical information.
Since resuming office recently, US President Donald Trump has reduced foreign aid and shut down the key foreign aid agency.
USAID had managed assistance for the US government, but Trump claimed its expenditure was "inefficient" and his administration was seeking direct bilateral deals to enhance transparency and responsibility.
Based on reports, Sixteen African countries have to date signed similar health pacts, representing more than $18.3bn in committed funds.
Details of the Rejected Agreement
This assistance for Zimbabwe would have gone towards "HIV/Aids treatment and prevention, TB, malaria, maternal and child health, and disease outbreak preparedness.
"It is our view this collaboration would have delivered significant benefits for Zimbabwean communities, especially the 1.2 million men, women and children presently receiving HIV treatment through US-supported initiatives," the Ambassador commented.
However, official spokesman Nick Mangwana argued the arrangement was "unequal".
"The proposal required Zimbabwe to surrender its genetic material and health information indefinitely, without any corresponding promise of benefiting from any medical innovations – like new medicines or tests – that could result from that shared data," he stated.
"Effectively, our nation would provide the raw materials for medical research without any assurance that the resulting innovations would be available to our citizens should a new disease outbreak emerge."
National Interest and Global Health
He also pointed out that the US's withdrawal from the World Health Organization (WHO) and its pursuit of one-on-one deals were disrupting frameworks already established via the international health agency.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing system designed to deal with potential global health emergencies.
"This framework is intended to ensure that when a country provides its samples, the benefits – including medicines and cures – are shared equitably, not monopolised exclusively by those with the resources to create them."
The government's concerns over the US deal "must not be interpreted as opposition to America," he added.
"We encourage further discussions with our American counterparts on how subsequent co-operation could be arranged in a way that honours the independence and interests of each country."
Health Experts Response
A leading public health body stated it recognised the official position, but suggested that talks need to persist since a large portion of the nation's HIV programmes were funded by external financing.
"If specific concerns exist, such as those relating to data governance or agreement terms, these can often be resolved via technical clarification and negotiated safeguards," the group said.
The halted deal underscores the ongoing challenges between receiving much-needed foreign assistance and safeguarding local interests in an increasingly data-driven world.